Himalaya Nutravedics India last traded at ₹115.85 (2026-10-13). Its closing range over 52 weeks is ₹112.65 – ₹135.00, with the latest close 14.2% below the high.
Closing prices up to 2026-10-13.
In the latest year (Mar 2026), Himalaya Nutravedics India reported sales of ₹43.06 crore (+105.0%) and net profit of ₹7.39 crore (+231.4%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 43.06 | 8.11 | 18.83 | 7.39 | 11.72 |
| Mar 2025 | 21.00 | 2.99 | 14.24 | 2.23 | 5.58 |
| Mar 2024 | 14.43 | 0.94 | 6.51 | 0.43 | 5.18 |
| Mar 2023 | 2.05 | 0.28 | 13.66 | 0.15 | 1.81 |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Sales growth | +603.9% | +45.5% | +105.0% |
| Operating profit growth | +235.7% | +218.1% | +171.2% |
| Net profit growth | +186.7% | +418.6% | +231.4% |
| EPS growth | +186.2% | +7.7% | +110.0% |
| OPM % | 6.5% | 14.2% | 18.8% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Himalaya Nutravedics India.
Get Free AI Stock Analysis FREE →No recent news available for Himalaya Nutravedics India.
Himalaya Nutravedics India shares were last quoted at ₹115.85 (-0.7% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Himalaya Nutravedics India has a price-to-earnings (P/E) ratio of 0.00 and a price-to-book (P/B) ratio of 5.72. The industry P/E is 52.29.
The 52-week high of Himalaya Nutravedics India is ₹123.90 and the 52-week low is ₹111.00.
The market capitalisation of Himalaya Nutravedics India is about ₹107.97 crore.
Promoters hold about 68.13% of Himalaya Nutravedics India.
Himalaya Nutravedics India belongs to the Pharmaceuticals & Drugs sector.